A Dhs80m factory aimed at improving cancer management for patients in the UAE and the region has been inaugurated by the Dubai Health Authority. The new facility, a joint venture with the Al Mulla Group and Monrol UAE, will manufacture the FDG (Flurodeoxglucose) injection that is required for patients who need to undergo PET (Positron Emission Tomography) scan.
Subscribe to MEED to receive your choice of premium newsletters
 |
 |
 |
 |
Identify and track projects across the Middle East and North Africa through MEED Projects. Subscribers can track projects, conduct trend analysis, forecast, produce strategic reports and ultimately win new business.
Middle East data, research and analysis - from broad macroeconomic statistics to specific sector data, MEED Insight can help you accurately and cost effectively forecast market growth and trends.
MEED Events provide high profile speakers, relevant and critical business content and the latest news from across the GCC. With a portfolio that includes large-scale summits, two-day industry specific conferences and unique networking opportunities.
Site powered by Webvision
Share
